Truveris, a McKesson Ventures portfolio company, has announced that it has elected Sally Welborn to its board of directors. Welborn brings 30+ years of industry experience to Truveris, which is working to provide everyone with access to affordable prescription medication.
Welborn expressed her support of Truveris’s mission, saying, “Prescription drug affordability and accessibility is one of the most important issues in the US today.” She continued, “Truveris has unique capabilities to make a difference for payers and patients, and I am honored to join its Board.”
Welborns prior work includes founding Welborn Advisory Services, serving as Senior Vice President of Global Benefits at Walmart, and working as Senior Vice President of Benefits at Wells Fargo. She is also a Board Advisor for the Penn Center for Health Incentives and Behavioral Economics. In addition, she is a member of the Board of the Leapfrog Group, among other qualifications.
Truveris CEO, Faisal Mushtaq commented that Welborn brings with her a “deep understanding of the challenges organizations face providing employee benefits,” noting that this will help Truveris as it continues to work toward its mission.
“Throughout her career, Sally has demonstrated that she is a strategic thinker with a record of success in implementing ground-breaking initiatives,” Mushtaq said. “She is a highly respected healthcare policy expert, and we look forward to benefitting from her experience as we work to provide greater access to affordable medications so that everyone can live healthier lives.”
To read more about Welborn’s election to the Truveris board of directors, read the press release here.